• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Emergency

Inhaled and intranasal ciclesonide for the treatment of COVID-19 in adult outpatients

byBipandeep AbbatandAlex Chan
November 10, 2021
in Emergency, Infectious Disease, Pulmonology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

RELATED REPORTS

Surveillance testing of staff at nursing facilities reduces resident COVID-19 mortality

SAR-CoV-2 infection during pregnancy may lead to adverse neurodevelopmental outcomes in male offspring

Molnupiravir and nirmatrelvir-ritonavir reduce COVID-19 mortality in hospitalized patients

1. In patients COVID-19, the combination of inhaled and intranasal ciclesonide did not show a statistically significant improvement of respiratory symptoms.

Evidence Rating Level: 1 (Excellent)

COVID-19 has represented a significant cause of morbidity and mortality since its emergence. Respiratory symptoms tend to be commonly present in those infected with this virus. Ciclesonide is a corticosteroid used in inhaled form to treat asthma and intranasally to treat allergic rhinitis. This randomised controlled trial aimed to evaluate whether early administration of ciclesonide decreases respiratory symptoms in adults with COVID-19. 203 participants were randomized to either inhaled and intranasal ciclesonide (n=105) or inhaled and intranasal saline placebo (n=98). The median age of participants was 35 years (interquartile range 27 – 46 years) and 109 (54%) were female. All included participants had confirmed covid-19 and at least one of the following symptoms: fever, cough, shortness of breath, chest congestion, or chest tightness). The primary outcome was defined as resolution of self-reported fever and all respiratory symptoms at day 7 of treatment. It was found that the proportion of participants with resolved symptoms by day 7 did not differ significantly between the intervention group (n = 42 from 105; 40%) and control group (n = 34 from 98; 35%). The adjusted risk difference was 5.5% (95% CI, -7.8% – 18.8%). The secondary outcomes included were hospital admission, death due to COVID-19, and resolution of symptoms by day 14. There were no statistically significant differences found in any of these outcomes. No deaths occurred during this study. 69 of 105 (66%) patients had resolution in the intervention group compared to 57 of 98 (58%) in placebo group, with an adjusted risk difference of 7.5% (95% CI, -5.9% – 20.8%). Therefore, the study concluded that younger healthier populations with COVID-19 did not improve respiratory symptoms. As this is one of the only trials focusing on this population, future directions for research should include examining different classes of inhaled corticosteroids to determine their effects.

Click to read the study in BMJ

Image: PD

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: COVID-19SARS-CoV-2
Previous Post

Maralixibat appears safe and efficacious for patients with Alagille syndrome and cholestatic pruritus

Next Post

Immune thrombocytopenia and thrombosis mortality predictors following SARS-CoV-2 vaccine

RelatedReports

Age may not impact residential status after abdominal surgery
Infectious Disease

Surveillance testing of staff at nursing facilities reduces resident COVID-19 mortality

March 31, 2023
Paternal factors associated with short interpregnancy interval
Infectious Disease

SAR-CoV-2 infection during pregnancy may lead to adverse neurodevelopmental outcomes in male offspring

March 29, 2023
SARS-CoV-2 detected on various surroundings of asymptomatic COVID-19 positive infant
Infectious Disease

Molnupiravir and nirmatrelvir-ritonavir reduce COVID-19 mortality in hospitalized patients

March 29, 2023
Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children
Chronic Disease

Past infection with pre-omicron variants of COVID-19 protects against re-infection

March 28, 2023
Next Post
Novel coronavirus identified from patients with pneumonia in Wuhan, China

Immune thrombocytopenia and thrombosis mortality predictors following SARS-CoV-2 vaccine

#VisualAbstract: Internal mammary node irradiation improves survival for patients with centromedially located node-positive breast cancer

#VisualAbstract: Low-dose computed tomography improves the detection of secondary primary lung cancers compared to chest radiographs for head and neck cancer survivors

Quick Take: Functional Outcome of Intravenous Thrombolysis in Patients With Lacunar Infarcts in the WAKE-UP Trial

No difference between noncontrast CT vs MRI for mechanical thrombectomy in patients with large vessel occlusion stroke

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Addition of fludrocortisone to hydrocortisone is beneficial in management of septic shock
  • Surveillance testing of staff at nursing facilities reduces resident COVID-19 mortality
  • Childhood maltreatment may cause mental health problems
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options